PT Kimia Farma Tbk (KAEF.JK)

Indonesia · Healthcare · IDR

Key financials

ROE: -16.56%; 2025 (actual)
ROA: -2.3%; 2025 (actual)
Gross Margin: 33.21%; 2025 (actual)
Net Margin: -3.63%; 2025 (actual)
Total Assets: IDR 14,183.18B; 2025 (actual)
Net Income: -IDR 334.96B; 2025 (actual)
Valuation: IDR 2,866.79B; 2025 (actual)
Stock Price: IDR 515; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-16.56%	-19.95%	-26.56%	-29.9%	-28.01%	-27.45%
Sector average	9.61%	8.15%	4.43%	106.09%	9.11%	-15.92%
ROA	-2.3%	-2.28%	-2.4%	-1.93%	-1.25%	-0.88%
Sector average	5.93%	6.11%	5.79%	5.8%	5.77%	5.49%
Gross Margin	33.21%	33.21%	33.21%	33.21%

Amounts in IDR (billions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for PT Kimia Farma Tbk? It covers the balance sheet, income statement and Equlion model projections.

Net Margin	-3.63%	-3.52%	-3.36%	-2.46%	-1.53%	-1.06%
Sector average	6.04%	6.25%	6.16%	6.45%	6.8%	6.99%

Total Assets	IDR 14,183.18B	IDR 13,752.44B	IDR 14,225.59B	IDR 15,442.13B	IDR 16,469.52B	IDR 17,085.45B
Sector average	IDR 7,353B	IDR 7,871.2B	IDR 8,776.94B	IDR 9,968.98B	IDR 11,181.14B	IDR 12,214.16B

Net Income	-IDR 334.96B	-IDR 317.87B	-IDR 336.36B	-IDR 285.65B	-IDR 199.64B	-IDR 147.93B
Sector average	IDR 335.05B	IDR 361.91B	IDR 409.48B	IDR 499.3B	IDR 586.99B	IDR 641.74B

Valuation	IDR 2,866.79B	IDR 2,720.52B	IDR 2,878.76B	IDR 2,444.74B	IDR 1,708.6B	IDR 1,266.05B
Sector average	IDR 14,416.13B	IDR 19,376B	IDR 20,324.94B	IDR 20,030.02B	IDR 18,971.81B	IDR 18,513.18B

Stock Price	IDR 515	IDR 488.72	IDR 517.15	IDR 439.18	IDR 306.94	IDR 227.44
Sector average	IDR 2,059.43	IDR 1,839.21	IDR 1,924.82	IDR 1,903.8	IDR 1,818.04	IDR 1,784.88